v3.26.1
Condensed Consolidated Statements of Changes in Stockholders' (Deficit) Equity - USD ($)
shares in Thousands, $ in Thousands
Common stock
Additional paid-in-capital
Accumulated deficit
Total
Beginning Balance at Dec. 31, 2024 $ 49 $ 557,047 $ (650,197) $ (93,101)
Beginning Balance (in shares) at Dec. 31, 2024 3,102      
Issuance of common shares, net of offering costs $ 10 471   481
Issuance of common shares, net of offering costs (in shares) 2,358      
Stock-based compensation   180   180
Issuance of pre-funded stock purchase warrants   9,523   9,523
Vesting of restricted stock units, net of employee tax obligations   (1)   (1)
Vesting of restricted stock units, net of employee tax obligations (in shares) 8      
Net Income (Loss)     (7,254) (7,254)
Ending Balance at Mar. 31, 2025 $ 59 567,220 (657,451) (90,172)
Ending Balance (in shares) at Mar. 31, 2025 5,468      
Beginning Balance at Dec. 31, 2024 $ 49 557,047 (650,197) (93,101)
Beginning Balance (in shares) at Dec. 31, 2024 3,102      
Net Income (Loss)       (26,441)
Ending Balance at Jun. 30, 2025 $ 60 568,911 (676,638) (107,667)
Ending Balance (in shares) at Jun. 30, 2025 6,620      
Beginning Balance at Mar. 31, 2025 $ 59 567,220 (657,451) (90,172)
Beginning Balance (in shares) at Mar. 31, 2025 5,468      
Issuance of common shares, net of offering costs $ 1 135   136
Issuance of common shares, net of offering costs (in shares) 1,146      
Stock-based compensation   1,556   1,556
Vesting of restricted stock units, net of employee tax obligations (in shares) 6      
Net Income (Loss)     (19,187) (19,187)
Ending Balance at Jun. 30, 2025 $ 60 568,911 (676,638) (107,667)
Ending Balance (in shares) at Jun. 30, 2025 6,620      
Beginning Balance at Dec. 31, 2025 $ 76 624,555 (720,094) $ (95,463)
Beginning Balance (in shares) at Dec. 31, 2025 22,328     22,328
Issuance of common shares, net of offering costs $ (49)      
Issuance of common shares, net of offering costs   1,518   $ 1,469
Issuance of common shares, net of offering costs (in shares) 4,746      
Stock-based compensation   532   532
Issuance of pre-funded stock purchase warrants   610   610
Vesting of restricted stock units, net of employee tax obligations (in shares) 1      
Net Income (Loss)     (12,691) (12,691)
Ending Balance at Mar. 31, 2026 $ 27 627,215 (732,785) (105,543)
Ending Balance (in shares) at Mar. 31, 2026 27,075      
Beginning Balance at Dec. 31, 2025 $ 76 624,555 (720,094) $ (95,463)
Beginning Balance (in shares) at Dec. 31, 2025 22,328     22,328
Net Income (Loss)       $ (27,404)
Ending Balance at Jun. 30, 2026 $ 31 632,007 (747,498) $ (115,460)
Ending Balance (in shares) at Jun. 30, 2026 31,305     31,305
Beginning Balance at Mar. 31, 2026 $ 27 627,215 (732,785) $ (105,543)
Beginning Balance (in shares) at Mar. 31, 2026 27,075      
Issuance of common shares, net of offering costs $ 4 4,458   4,462
Issuance of common shares, net of offering costs (in shares) 4,047      
Stock-based compensation   358   358
Vesting of restricted stock units, net of employee tax obligations   (24)   (24)
Vesting of restricted stock units, net of employee tax obligations (in shares) 183      
Net Income (Loss)     (14,713) (14,713)
Ending Balance at Jun. 30, 2026 $ 31 $ 632,007 $ (747,498) $ (115,460)
Ending Balance (in shares) at Jun. 30, 2026 31,305     31,305